4//SEC Filing
Lorenzo Pierre 4
Accession 0001140361-21-022781
CIK 0001544227other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 9:53 PM ET
Size
12.0 KB
Accession
0001140361-21-022781
Insider Transaction Report
Form 4
Lorenzo Pierre
Corporate Controller
Transactions
- Award
Stock Option (Right to Buy)
2021-06-25+48,535→ 48,535 totalExercise: $26.40Exp: 2031-04-28→ Common Stock (48,535 underlying) - Award
Common Stock
2021-06-25+53→ 53 total - Award
Stock Option (Right to Buy)
2021-06-25+1,234→ 1,234 totalExercise: $10.25Exp: 2031-03-09→ Common Stock (1,234 underlying) - Award
Stock Option (Right to Buy)
2021-06-25+4,830→ 4,830 totalExercise: $5.90Exp: 2030-11-15→ Common Stock (4,830 underlying)
Footnotes (4)
- [F1]In connection with the merger of Millendo Therapeutics, Inc. ("Millendo") and private company Tempest Therapeutics, Inc. ("Tempest"), pursuant to the Agreement and Plan of Merger dated March 29, 2021 (the "Merger Agreement"), which closed on June 25, 2021 ("Closing"), (i) each share of Tempest's common stock converted into the right to receive approximately 0.0322 shares of Millendo common stock (the "Exchange Ratio"), and (ii) each outstanding and unexercised option to purchase shares of Tempest common stock converted into an option to purchase shares of Millendo's common stock, with necessary adjustments to reflect the Exchange Ratio but otherwise the same terms and conditions. The Exchange Ratio gives effect to the 15-to-1 reverse stock split of Millendo's common stock. On the Closing date, the closing price of Millendo common stock was $1.06 (unadjusted). Upon Closing, Millendo was renamed "Tempest Therapeutics, Inc."
- [F2]One-fourth of the shares underlying this option vest on November 16, 2021, and the remaining shares vest in a series of 36 equal monthly installments thereafter, subject to the reporting person's continued service.
- [F3]These stock options vest in a series of 48 equal monthly installments measured from the vesting commencement date of March 5, 2021, subject to the reporting person's continued service.
- [F4]These stock options vest in a series of 48 equal monthly installments measured from the vesting commencement date of Closing, June 25, 2021, subject to the reporting person's continued service.
Documents
Issuer
Millendo Therapeutics, Inc.
CIK 0001544227
Entity typeother
Related Parties
1- filerCIK 0001869915
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 9:53 PM ET
- Size
- 12.0 KB